Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19)
AR Bourgonje, AE Abdulle, W Timens… - The Journal of …, 2020 - Wiley Online Library
Abstract Angiotensin‐converting enzyme 2 (ACE2) has been established as the functional
host receptor for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus …
host receptor for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus …
Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence
The symptoms most commonly reported by patients affected by coronavirus disease (COVID-
19) include cough, fever, and shortness of breath. However, other major events usually …
19) include cough, fever, and shortness of breath. However, other major events usually …
Pathophysiology of COVID-19: why children fare better than adults?
The world is facing Coronavirus Disease-2019 (COVID-19) pandemic, which is causing a
large number of deaths and burden on intensive care facilities. It is caused by Severe Acute …
large number of deaths and burden on intensive care facilities. It is caused by Severe Acute …
Extra-respiratory manifestations of COVID-19
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has become a global health threat. Although most …
syndrome coronavirus 2 (SARS-CoV-2), has become a global health threat. Although most …
Pulmonary embolism or pulmonary thrombosis in COVID-19? Is the recommendation to use high-dose heparin for thromboprophylaxis justified?
M Cattaneo, EM Bertinato, S Birocchi… - Thrombosis and …, 2020 - thieme-connect.com
Acutely ill medical patients are at heightened risk for venous thromboembolism, a term that
combines deep vein thrombosis (DVT) and its more severe complication, pulmonary …
combines deep vein thrombosis (DVT) and its more severe complication, pulmonary …
Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review
Y Sakr, M Giovini, M Leone, G Pizzilli, A Kortgen… - Annals of intensive …, 2020 - Springer
Background Preliminary reports have described significant procoagulant events in patients
with coronavirus disease-2019 (COVID-19), including life-threatening pulmonary embolism …
with coronavirus disease-2019 (COVID-19), including life-threatening pulmonary embolism …
Thrombotic complications of COVID-19
Introduction The novel coronavirus disease of 2019 (COVID-19) is associated with
significant morbidity and mortality. The impact of thrombotic complications has been …
significant morbidity and mortality. The impact of thrombotic complications has been …
Functional role of dietary intervention to improve the outcome of COVID-19: a hypothesis of work
Background: On the 31 December 2019, the World Health Organization (WHO) was
informed of a cluster of cases of pneumonia of unknown origin detected in Wuhan City …
informed of a cluster of cases of pneumonia of unknown origin detected in Wuhan City …
SARS-CoV-2 and coagulation disorders in different organs
S Vinayagam, K Sattu - Life sciences, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) is a prominent pandemic disease that
emerged in China and hurriedly stretched worldwide. There are many reports on COVID-19 …
emerged in China and hurriedly stretched worldwide. There are many reports on COVID-19 …
Modeling lung perfusion abnormalities to explain early COVID-19 hypoxemia
Early stages of the novel coronavirus disease (COVID-19) are associated with silent hypoxia
and poor oxygenation despite relatively minor parenchymal involvement. Although …
and poor oxygenation despite relatively minor parenchymal involvement. Although …